Impact Biomedical (IBO) Assets Average (2023 - 2026)
Impact Biomedical's (IBO) quarterly Assets Average came in at $17.2 million in Q1 2026, down 14.5% YoY from $20.2 million in Q1 2025, and down 3.15% on a QoQ basis from $17.8 million in Q4 2025.
Impact Biomedical (IBO) Assets Average (2023 - 2026) Analysis & Trends
Impact Biomedical (IBO) has 4 years of Assets Average data on file, last reported at $17.2 million in Q1 2026.
- Quarterly Assets Average fell 14.5% year-over-year to $17.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.2 million (down 14.5% YoY) and the FY2025 annual result came in at $18.8 million, down 41.94% from the prior year.
- Assets Average retreated to $17.2 million in Q1 2026, from $17.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $45.5 million in Q3 2023 to a low of $17.2 million in Q1 2026.
- A 4-year average of $31.9 million and a median of $33.5 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2024 — Assets Average fell 0.29% — and 2025, when it tumbled 58.96%.
- Tracing IBO's Assets Average over 4 years: stood at $44.9 million in 2023, then decreased by 25.34% to $33.5 million in 2024, then plunged by 46.83% to $17.8 million in 2025, then dropped by 3.15% to $17.2 million in 2026.
- The last three Assets Average figures came in at $17.2 million (Q1 2026), $17.8 million (Q4 2025), and $18.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Impact Biomedical | 49.45 Mn | 49.44 Mn | 2,000.00 | 16.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.92 Mn |
| Mar 31, 2026 | 17.25 Mn |
| Dec 31, 2025 | 17.81 Mn |
| Sep 30, 2025 | 18.63 Mn |
| Jun 30, 2025 | 19.56 Mn |
| Mar 31, 2025 | 20.17 Mn |
| Dec 31, 2024 | 33.49 Mn |
| Sep 30, 2024 | 45.41 Mn |
| Jun 30, 2024 | 44.24 Mn |
| Mar 31, 2024 | 44.49 Mn |
| Dec 31, 2023 | 44.86 Mn |
| Sep 30, 2023 | 45.54 Mn |